There is no observation of the fatty changes and inflammation in the liver of MetS (PLP), lower NF-kB expression (Figure 1) and its triggers (Table 2 & 3), the enzyme activities (Table 2), and higher anti-oxidant capacity of the liver (Table 3) and the Glo-I activity satisfies the hepatoprotective and anti-inflammatory properties of PLP and its preventive effect on acute hepatitis. Here, NFKB1 is linked to metabolic syndrome.